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Background: Impaired diabetic wound healing occurs as a consequence of excessive reactive oxygen species (ROS)
and inflammatory cytokine production. We previously found that whey protein (WP) was able to normally regulate
the ROS and inflammatory cytokines during the inflammatory phase (first day) in streptozotocin (STZ)-diabetic
wound healing. This study was designed to assess the effect of WP on metabolic status, the inflammation and
anti-inflammation response, oxidative stress and the antioxidant defense system during different phases of the
wound healing process in diabetic rats. WP at a dosage of 100 mg/kg of body weight, dissolved in 1% CMC, was
orally administered daily to wounded normal (non-diabetic) and STZ-induced diabetic rats for 8 days starting from
the 1st day after wounding.
Results: The data revealed that WP enhanced wound closure and was associated with an increase in serum insulin
levels in diabetic rats and an alleviation of hyperglycemic and hyperlipidemic states in diabetic animals. The
increase in insulin levels as a result of WP administration is associated with a marked multiplication of β-cells in the
core of islets of Langerhans. WP induced a reduction in serum TNF-α, IL-1β and IL-6 levels and an increase in IL-10
levels, especially on the 4th day after wounding and treatment. WP also suppressed hepatic lipid peroxidation and
stimulated the antioxidant defense system by increasing the level of glutathione and the activity of glutathione-S-
transferase, glutathione peroxidase and superoxide dismutase (SOD) in wounded diabetic rats.
Conclusions: WP was observed to enhance wound closure by improving the diabetic condition, limiting
prolonged inflammation, suppressing oxidative stress and elevating the antioxidant defense system in diabetic rats.
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Diabetes is a complex metabolic disorder involving
many organs and can devastate the lives of affected
individuals [1]. Impaired wound healing is a complica-
tion of diabetes and a serious problem in clinical prac-
tice [2]. As many as 15% of people with diabetes will
develop foot ulceration and wounds, and 3% will* Correspondence: hossamebaid@yahoo.com
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reproduction in any medium, provided the orrequire lower limb amputation [3]. In addition, an in-
creased incidence of wound complications in surgical
patients with diabetes mellitus increases the general
surgical risks due to the metabolic abnormalities asso-
ciated with diabetes mellitus [4].
In humans and in all mammalian species, the wound
healing process can be subdivided into distinct consecu-
tive and overlapping stages: hemostasis, inflammation
and debridement, new tissue formation and remodeling
[5,6]. Neutrophils and macrophages play a key role intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tokines and a variety of growth factors [7].
Oxidative stress occurs due to an imbalance between
the production of reactive oxygen species (ROS) and
protection by cellular anti-oxidants [8]. Increased pro-
duction of ROS and decreased antioxidant defense can
cause tissue injury or even cell death, which can occur
by necrosis and apoptosis [9]. Oxidative stress has been
implicated in the pathology of diabetes mellitus [10], a
disease marked by a prolonged inflammatory period that
increases the time required for recovery. In addition,
Mohammad et al. [11] stated that impaired wound
healing occurs as a consequence of excessive ROS pro-
duction. Thus, elimination of reactive oxygen species is
an important strategy to improve the healing of wounds
in diabetes mellitus patients.
Whey protein (WP) contains all of the essential and
nonessential amino acids and is a good source of glu-
tamine and the branched-chain amino acids that are ne-
cessary for cell growth [12]. The healing of bone, skin
and muscle tissue is stimulated by the branch-chain
amino acids leucine, isoleucine and valine. The amino
acid proline aids in the production of collagen, thereby
healing cartilage and strengthening joints, tendons and
cardiac muscle [13]. In addition, WP has been found to
significantly suppress hydroperoxide and ROS levels in
leukocytes, liver and cutaneous tissues in mice by stimu-
lating production of the antioxidant glutathione [14]. In
addition, we previously observed that the in vitro
chemotaxis of B cells, T cells and bone marrow-derived
dendritic cells toward CCL-21 and CXCL-12 was signifi-
cantly increased after WP administration [15].
Data from our previous work indicate that WP in-
creases the capacity of non-diabetic [16] and diabetic
[17] animals to heal wounds. That study revealed the po-
tential effects of WP on immune processes, including
the regulation of cytokines during inflammatory phase
of healing process. Here, after inducing diabetes, we
followed oxidative stress and sequential inflammatory
and anti-inflammatory cytokines, and metabolic state to
address whether WP can be able to limit the diabetic
prolonged inflammation during proliferation and remod-
eling phases of cutaneous wound healing.
Methods
Preparation of whey proteins
Camel milk was obtained from a camel breed (Majaheem)
from the Najd region in Saudi Arabia. The milk was
skimmed by centrifugation at 5000 g for 20 min using an
IEC Model K centrifuge [Boston, USA]. Skim milk was
acidified to pH 4.3 using 1 M HCl. The precipitated casein
was removed by centrifugation, and the supernatant
containing the whey protein was saturated with ammo-
nium sulfate (70% saturation) and incubated overnight at4°C. The precipitated whey protein was collected by cen-
trifugation and dialyzed against distilled water for 48 h at
4°C using a Spectra/Pro® Membrane, MWCO 6000-8000
Da. The obtained dialyzate was lyophilized using a Unitop
600SL, [Virtis Company, Gardiner, New York 12525 USA]
and were kept at -20°C until use. The dialyzate containing
non-denatured whey protein was freeze-dried and refriger-
ated until use.
Ethical approval
All animal procedures were conducted in accordance
with the standards set forth in the guidelines for the care
and use of experimental animals by the Committee for
the Purpose of Control and Supervision of Experiments
on Animals (CPCSEA) and the National Institutes of
Health (NIH). The study protocol was approved by the
Animal Ethics Committee of the Zoology Department in
the College of Science at Beni-Suef University.
Experimental animals
Male albino rats (Rattus rattus) weighing approximately
150-180 g were used as experimental animals in this
study. The animals were housed in standard polypropyl-
ene cages with aerated, stainless steel covers, maintained
at a controlled temperature (22 ± 2°C) with a 12 h light/
dark cycle and were fed a standard diet of known com-
position with water ad libitum.
Diabetic models
Diabetes was induced by a single injection of freshly
dissolved STZ (50 mg/kg of body weight; Sigma, USA)
in a 0.1 mol/l citrate buffer (pH 4.5) into the peritoneum
[18]. Control rats were injected with citrate buffer. Seven
days after STZ injection, rats were screened for serum
glucose levels. Rats with a serum glucose level ≥ 200 mg/
dl after 2 hours of glucose intake were considered dia-
betic and selected for further studies.
Experimental design
The supplemented volume for all groups was constant
and did not exceed 250 μl per dosage per day. The opti-
mal dose of WP was determined in our laboratory on
the basis of the LD50 and several established studies and
parameters. The animals were allocated into 6 groups of
12 animals each, assigned as follows:
1. Uninjured control group (Non-wounded normal:
Non-wounded N) that were orally supplemented
with distilled water (250 μl/mouse/day).
2. Wounded non-diabetic group with daily
administration of the vehicle (250 μl/mouse/day), 1%
carboxymethyl cellulose (CMC), by gastric
intubation for 4 days (n = 6) or by gastric intubation
for 8 days (n = 6) (Wounded normal: N).
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administration of WP at 100 mg/kg of body weight
(250 μl/mouse/day), dissolved in 1% CMC, by gastric
intubation either for 4 days (n = 6) or for 8 days (n =
6) (WP-treated wounded normal: WPN).
4. Uninjured diabetic group (Non-wounded diabetic:
Non-wounded D) that were orally supplemented
with distilled water (250 μl/mouse/day).
5. Wounded diabetic group with daily administration
of 1% CMC (250 μl/mouse/day) by gastric
intubation for 4 days (n = 6) or by gastric intubation
for 8 days (n = 6) (Wounded diabetic: D).
6. Wounded diabetic group with daily treatment of
WP at 100 mg/kg of body weight (250 μl/mouse/
day) by gastric intubation either for 4 days (n = 6) or
for 8 days (n = 6) (WP-treated wounded diabetic:
WPD).
Excisional wound preparation
Rats were anesthetized, and the back of the rat was
shaved and sterilized using an alcohol swab. The wound
biopsy model used in this experiment was performed as
previously described [19] with slight modification. The
shaved skin was pinched and folded, and the wound was
punched through the full thickness of the folded skin to
form a 2 × 5 mm rectangle below the shoulder blades of
each rat.
Wounds from individual rats were digitally photo-
graphed every day. A standard rectangle equivalent in size
to the initial wound area was drawn beside the wound and
used as a reference. Wound size was calculated by deter-
mining the area of the wound each day in comparison to
the area of the standard rectangle. Wound closure was
expressed as the ratio of the initial wound size to the
wound area (each day after wounding). A higher ratio in-
dicates faster wound closure.
Blood and tissue sampling
At the end of the experiment, animals were sacrificed,
and blood samples were obtained from the carotid ar-
tery. Then, animals were decapitated and dissected, and
livers as well as pancreases of were rapidly excised.
Blood samples were left to coagulate and then were
centrifuged, and clear non-hemolyzed serum was kept at -
20ºC until used. Livers were kept at -20ºC pending
homogenization while pancreases were fixed in neutral
buffered formalin and transferred to Pathology Depart-
ment, National Cancer Institute (Cairo, Egypt) for
blocking, sectioning and staining with modified aldehyde
fuchsin method [20].
Estimation of cytokines
The levels of TNF-α and IL-10 in the serum of control
and experimental groups were determined using specificELISA kits purchased from R and A Systems, USA.
Serum IL-1β and IL-4 ELISA kits were obtained from
Thermo Scientific (USA) and Invitrogen (Canada). The
concentrations of TNF-α, IL-1β, IL-4 and IL-10 were
determined using a spectrophotometer at 450 nm according
to the manufacturers’ instructions. Standard plots were
constructed using standards, and the concentrations
for unknown samples were calculated from the stan-
dard plot.Estimation of glucose concentration
Serum glucose concentration was determined accor-
ding to the Trinder method [21] using a commercial
diagnostic kit (Biodiagnostics, Egypt). Serum insulin
was assayed in the Radioactive Isotopes Unit, Middle
Eastern Regional Radioisotope Center (Dokki, Giza)
using a DPC radioimmunoassay kit (Diagnostic Prod-
ucts Corporation, Los Angeles, USA) [coat-A-count]
according to the method reported by Marschner et al. [22].Estimation of serum lipids
Serum triglycerides [23], cholesterol [24] and HDL-
cholesterol [25] were estimated using a reagent kit
(Biodiagnostics, Egypt). The serum LDL-cholesterol
level was calculated using the Friedewald [26] formula
(LDL cholesterol = total cholesterol – triglycerides/5 –
HDL cholesterol). The serum vLDL-cholesterol con-
centration was calculated according to the Nobert [27]
formula (vLDL-cholesterol = triglycerides/5). Cardiovas-
cular risk indices were calculated by dividing the total
cholesterol and the LDL-cholesterol level by the HDL-
cholesterol level.Oxidative stress parameters
Liver lipid peroxidation, reduced glutathione, super-
oxide dismutase and peroxidase activities were also
measured according to the methods of Preuss et al.
[28], Beutler et al. [29], Marklund & Marklund [30]
and Kar & Mishra [31], respectively. The total antioxi-
dant levels in serum were assayed as previously de-
scribed Koracevic et al. [32] using a reagent kit
purchased from Biodiagnostics (Egypt).Statistical analysis
The data were analyzed using a one-way analysis of
variance (ANOVA) (PC-STAT, University of Georgia,
1985) followed by the LSD test to compare various
groups with each other. The results were expressed as
the mean ± SE, and values of P > 0.05 were not consid-
ered significantly different, whereas values of P < 0.05
and P < 0.01 were considered significant and highly
significant, respectively.
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Wound healing requires a prolonged period of time in
diabetic rats. The results indicated that the time required
to heal wounds was significantly decreased in diabetic
rats supplemented with WP compared with diabetic rats
treated with vehicle.
Effect of WP on the islets' β-cells
The photomicgraphs of pancreatic sections illustrated
that the administration of WP to wounded normal rats
for 8 days augmented the multiplication of islets' cell.
The islets have larger size with increased number of
granulated β-cells which seemed to have a higher div-
ision rate as compared to normal wounded control. On
the other hand, the diabetic wounded rats exhibited
marked decrease in the number of islets' cells associated
with hydropic degenerations and pyknosis in the islets.
The administration of WP to the diabetic wounded rats
for 8 days produced a potential improvement in the is-
lets. The β-cells seemed highly proliferated and densely
granulated (Figure 1).
Effects of WP on the insulin and glucose levels, and
wound closure
The effect of WP on serum fasting glucose and insulin
levels is depicted in Figure 2. Serum glucose concentrationFigure 1 Photomicrographs of pancreas sections of normal wounded
diabetic wounded control (C) and diabetic wounded rats treated with WP
administration is associated with a marked multiplication of β-cells in the c
beta cells; d: delta cells; hdv: highly divided beta cells; S: septae separating
(Modified aldehyde fuchsin method; 400x).was not significantly affected in wounded non-diabetic
rats regardless of WP treatment on the 4th and 8th day
after wounding. It was very significantly elevated (p < 0.01;
LSD) in uninjured and wounded diabetic rats compared
with control rats. Oral administration of WP to wounded
diabetic rats for 4 or 8 days potentially induced amelior-
ation (p < 0.01; LSD) of the elevated serum glucose levels.
The serum insulin concentration, on the other hand, was
markedly increased as a result of treating wounded non-
diabetic and diabetic rats for 4 and 8 days, compared with
the corresponding untreated wounded and uninjured
groups. The enhancement of insulin level was more pro-
nounced if the treatment was extended from 4 to 8 days.
A one-way analysis of variance (ANOVA) indicated that
the effect between groups on serum glucose and C-
peptide is highly significant (p < 0.001; F-prob.) through-
out the experiment (Figure 2). All wounded diabetic ani-
mals treated with WP achieved complete healing by day 8
(Figure 3).
Effects of WP on the serum lipid profile
The serum lipid profile, including triglycerides (TG),
total cholesterol (TC), LDL-cholesterol (LDL-C), HDL-
cholesterol (HDL-C) and vLDL-cholesterol (vLDL-C) as
well as the cardiovascular risk indices represented by the
ratios of TC and LDL-C to HDL-C are represented incontrol. (A), normal wounded rats treated with WP for 8 days (B),
for 8 days (D). The increase in insulin levels as a result of WP
ore of islets of Langerhans. IL: islets of Langerhans; a: alpha cells; b:
pancreatic lobules; hc: hydropic cells; n: necrosis; pk: pyknotic nuclei
Figure 2 Effect of whey protein administration on serum glucose and insulin concentrations of wounded normal and wounded
streptozotocin-induced diabetic rats. Oral administration of WP to wounded diabetic rats for 4 or 8 days potentially induced amelioration of
the elevated serum glucose levels. The serum insulin concentration was markedly increased as a result of treating wounded non-diabetic and
diabetic rats for 4 and 8 days. Non-wounded N; wounded normal: N; Whey protein-treated wounded normal: WPN; Non-wounded diabetic:
Non-wounded D; Wounded diabetic: D; Whey protein-treated wounded diabetic: WPD.
Figure 3 Photograph of external cutaneous wound healing process in control and different treated groups. Whey protein enhanced
wound closure in diabetic models. This figure reveals that WP enhanced wound closure process in non-diabetic and diabetic rats. Non-wounded
N; wounded normal: N; Whey protein-treated wounded normal: WPN; Non-wounded diabetic: Non-wounded D; Wounded diabetic: D;
Whey protein-treated wounded diabetic: WPD.
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dices were not significantly affected by wounding or by
WP treatment of wounded non-diabetic and diabetic
rats. The uninjured and wounded diabetic rats exhibited
a significant increase in the levels of TG, TC, LDL-C
and vLDL-C as well as the ratios of TC and LDL-C to
HDL-C compared with control rats. The treatment of
wounded diabetic rats with WP for 4 and 8 days induced
potential amelioration of the altered parameters. One-
way ANOVA indicated that the effect on serum TG, TC,
vLDL-C and LDL-C/HDL-C levels between groups was
highly significant (p < 0.01; F-prob.), and the effect on
serum LDL-C and TC/HDL-C was very highly signifi-
cant (p < 0.001) (Table 1).
Regulation of TNF-α, IL-1β, IL-6 and IL-10 by
supplementation with WP
Serum TNF-α levels were only significantly (p < 0.01;
LSD) increased in wounded diabetic rats 4 days after
wounding but were not significantly (p > 0.05; LSD) in-
creased in wounded non-diabetic rats compared with
the corresponding uninjured control (Figure 4). The
treatment of wounded diabetic rats with WP for 4 days
successfully decreased (p < 0.01; LSD) the elevated TNF-
α level to values close to normal. Serum IL-1β levels
were detectably increased in wounded non-diabetic and
wounded diabetic rats compared with the corresponding
uninjured control (Figure 5); serum IL-1β levels were sig-
nificantly elevated in wounded non-diabetic and wounded
diabetic rats on the 2nd and 8th day after wounding. The
treatment of wounded non-diabetic rats with WP pro-
duced an insignificant decrease (p > 0.05; LSD), whereas
the treatment of wounded diabetic rats induced a signifi-










Non-wounded N 48.46 ± 3.62c 53.59 ± 3.67c 20.76 ± 2.05d
N (4 days) 47.01 ± 3.35c 56.89 ± 8.15c 20.80 ± 2.71d
N (8 days) 62.91 ± 2.56c 46.08 ± 4.87c 17.45 ± 1.36d
WPN (4 days) 65.19 ± 2.06c 64.59 ± 4.61bc 23.55 ± 1.74cd
WPN (8 days) 69.23 ± 9.05c 57.04 ± 8.86c 22.61 ± 1.53d
Non-wounded D 87.08 ± 6.72bc 85.89 ± 6.78ab 38.80 ± 3.48a
D (4 days) 160.59 ± 16.69ab 85.59 ± 4.56ab 38.19 ± 3.31ab
D (8 days) 90.43 ± 3.27bc 53.11 ± 5.28c 18.98 ± 0.87d
WPD (4 days) 219.51 ± 64.57a 88.05 ± 8.73a 36.70 ± 3.06ab
WPD (8 days) 84.33 ±7.60bc 53.75 ± 5.96c 16.83 ± 2.13d
F-probability p < 0.01 p < 0.01 p < 0.001
LSD at the 5% level 7.68 22.67 8.41
LSD at the 1% level 10.34 30.53 11.32
The means, which share the same superscript symbol(s) are non-significantly differeserum IL-6 levels were profoundly increased in wounded
non-diabetic and wounded diabetic rats. The treatment of
wounded animals for 2 days produced no change in IL-6
concentration but induced a profound decrease on the 4th
and 8th day compared with the corresponding wounded
controls (Figure 6). By contrast, serum IL-10 levels were
significantly decreased in wounded non-diabetic and dia-
betic rats. The administration of WP to wounded non-
diabetic and diabetic rats induced a significant decrease
(p < 0.05; LSD) of IL-10 levels on the 4th day after woun-
ding (Figure 7). One-way ANOVA revealed that the effect
between groups was highly significant for the serum TNF-α
levels (p < 0.01; F-prob.) but was very highly significant (p <
0.001) for IL-1β, IL-6 and IL-10 levels.
Stimulating oxidative stability by supplementation
with WP
The liver lipid peroxidation increased in wounded non-
diabetic, uninjured diabetic and wounded diabetic rats
compared with uninjured controls. Of the treated groups,
only wounded diabetic rats treated with WP for 8 days
exhibited a significant decrease in comparison to the
corresponding wounded diabetic control. Glutathione
content in the liver was significantly decreased (p < 0.05;
LSD) in diabetic rats 8 days after wounding, and the WP
treatment of these animals produced a highly significant
increase, returning the value closer to control ones.
Glutathione-S-transferase activity in the liver was greatly
increased due to 8 days of WP treatment in wounded
non-diabetic and wounded diabetic rats. Glutathione per-
oxidase activity in the liver increased in non-diabetic
treated rats 8 days after wounding compared with the cor-
responding wounded non-diabetic control. The uninjured






33.87 ± 1.24a 9.70 ± 0.72c 0.61 ± 0.44c 1.61 ± 0.04d
33.74 ± 2.06a 9.41 ± 0.67c 0.65 ± 0.06c 1.73 ± 0.07d
25.49 ± 3.62a 12.58 ± 0.51c 0.72 ± 0.06bc 1.78 ± 0.05d
37.78 ± 5.71a 13.04 ± 0.41c 0.63 ± 0.09c 1.79 ± 0.20d
31.84 ± 3.42a 13.30 ± 1.81c 0.76 ± 0.06bc 1.75 ± 0.08d
32.53 ± 0.96a 17.26 ± 1.68bc 1.25 ± 0.10a 2.55 ± 0.13a
39.43 ± 3.21a 32.12 ± 3.34ab 1.00 ± 0.12ab 2.20 ± 0.11bc
29.56 ± 4.59a 18.32 ± 0.63bc 0.64 ± 0.11c 1.88 ± 0.09cd
45.53 ± 1.76a 43.91 ± 12.91a 0.82 ± 0.12bc 2.33 ± 0.16ab
32.69 ± 3.43a 16.87 ± 1.52bc 0.71 ± 0.10bc 1.87 ± 0.12cd
p > 0.05 p < 0.01 p < 0.01 p < 0.001
- 15.34 0.32 0.34
- 20.66 0.43 0.46
nt.
Figure 4 Effect of whey protein administration on serum TNF-α concentration in wounded normal and wounded diabetic rats. WP
induced a reduction in serum TNF-α level especially on the 4th day after wounding and treatment. Non-wounded N; wounded normal: N; Whey
protein-treated wounded normal: WPN; Non-wounded diabetic: Non-wounded D; Wounded diabetic: D; Whey protein-treated wounded diabetic:
WPD. F. Prob.: p < 0.01; LSD at the 5% level: 17.72; LSD at the 1% level: 23.86. The means, which share the same superscript symbol(s) are
non-significantly different.
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groups. Treating wounded diabetic rats with WP did not
induce a significant effect compared with the corres-
ponding wounded diabetic control. Liver SOD activity
was significantly decreased in uninjured diabetic and
wounded diabetic rats compared with wounded and un-
injured non-diabetic rats. The treatment of wounded
diabetic rats with WP produced a significant increase
(p < 0.05; LSD) on the 4th day after wounding and treat-
ment. With regard to the ANOVA test, the effect be-
tween groups on glutathione content and SOD activity
was significant (p < 0.05; F-prob.). Although the general
effect on lipid peroxidation was highly significant, the
effect on glutathione-S-transferase and glutathione per-
oxidase activities was very highly significant (Figure 8).
Discussion and conclusions
Wound healing begins immediately after injury and
proceeds by well-organized integration and interaction
between different types of cells and tissues. Wound
healing is characterized by centripetal movement of the
wound edge toward the center of the wound, produ-
cing wound closure. The process of wound healing canbe divided into five phases – the cellular phase (granu-
lation), narrowing of the wound area (wound con-
traction), collagen deposition (collagenation), epithelial
covering (epithelialization) and scar remodeling (cicatri
zation). These phases are overlapping, and any agent
that accelerates the process promotes wound healing
[33,34]. Diabetes mellitus delays wound healing by af-
fecting these processes [35,36].
Examination of the wounds in this study demonstrated
that although diabetes mellitus slows wound healing,
daily WP administration after wounding hastens wound
closure in both diabetic and non-diabetic rats. These re-
sults are consistent with those of Ebaid et al. [17], who
revealed that WP supplementation improved both the
healing and closure of diabetic wounds.
The enhancement of wound healing in WP-treated dia-
betic rats was concomitant with a potential improvement
in the glycemic state and alleviation of the lowered serum
insulin levels. Furthermore, non-diabetic rats that were or-
ally administered WP daily for 4 or 8 days exhibited an
enormous increase in serum insulin levels consistent with
enhanced wound closure, although serum fasting glucose
levels were not significantly affected. These results are in
Figure 5 Effect of whey protein administration on serum IL-1β concentration in wounded normal and wounded diabetic rats. WP was
found to induce a reduction in serum IL-1β level on the 4th day after wounding and treatment. Non-wounded N; wounded normal: N; Whey
protein-treated wounded normal: WPN; Non-wounded diabetic: Non-wounded D; Wounded diabetic: D; Whey protein-treated wounded diabetic:
WPD. F. Prob.: p < 0.001; LSD at the 5% level: 5.99; LSD at the 1% level: 8.07. The means, which share the same superscript symbol(s) are
non-significantly different.
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that WP has insulinotropic effects in non-diabetic and dia-
betic conditions. As reported in previous studies, WP con-
tains many amino acids at varying concentrations [38].
Most of these amino acids are likely to act as insulin secre-
tagogues after WP supplementation. It is well known that
amino acids stimulate insulin release from pancreatic
β-cells both alone and in combination [39-41]. The mech-
anism by which amino acids induce insulin release from
β-cells is complex, and several metabolic pathways are ac-
tivated, depending on the type of amino acid [38,40]. In
addition to the insulinotropic action of amino acids, WP
produced an increase in the plasma glucose-dependent
insulinotropic polypeptide after ingestion [38]. In addition
to the stimulatory effects of whey protein on insulin secre-
tion, the present study revealed that the administration of
whey protein to normal and diabetic wounded rats en-
hanced the proliferation and multiplication of β-cells
which seemed to be more granulated in the treated ani-
mals. Thus, this also provides evidence that support the
hypothesis that whey protein increased insulin levels in
both normal and diabetic rats.
The direct positive effect of insulin on the enhance-
ment of wound healing has been unclear in previous
publications. However, many studies [42-44] found thatinsulin treatment by topical application or by injection
accelerated wound healing. By contrast, Weringer et al.
[45] revealed that there was no detectable difference in
the duration of the healing response in either insulin-
treated or non-treated diabetic mice.
Hyperlipidemia with or without diabetes mellitus
may impair wound healing [46,47]. The diabetic rats in
the present study exhibited a profound elevation in
total cholesterol, triglycerides, LDL-cholesterol and
vLDL-cholesterol levels. The cardiovascular risk indi-
ces, represented by the ratios of total cholesterol levels
and LDL-cholesterol to HDL-cholesterol levels, were
also remarkably increased. These changes may cause
deterioration of the process of healing. Sen et al. [46]
reported that re-epithelialization was reduced in hyper-
cholesterolemic mice. Jang et al. [10] observed that
hypercholesterolemia is associated with angiogenic im-
pairment, which in turn delayed wound healing. WP
treatment of wounded diabetic rats produced marked
amelioration of the tested serum lipids and the calcu-
lated cardiovascular risk indices, which may be second-
ary to the improvement of serum insulin level. Based
on our results and previous publications, it can be con-
cluded that the alleviation of serum lipids and cardio-
vascular risk indices may be involved, at least in part,
Figure 6 Effect of whey protein administration on serum IL-6 concentration in wounded normal and wounded diabetic rats. WP
induced a reduction in serum IL-6 levels and on the 4th day after wounding and treatment. Non-wounded N; wounded normal: N; Whey
protein-treated wounded normal: WPN; Non-wounded diabetic: Non-wounded D; Wounded diabetic: D; Whey protein-treated wounded diabetic:
WPD. F. Prob.: p < 0.001; LSD at the 5% level: 10.86; LSD at the 1% level: 14.62. The means, which share the same superscript symbol(s) are
non-significantly different.
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rats treated with WP.
In our previous study [17], the early changes in in-
flammatory cytokines (IL-1β, TNF-α and IL-6) during
the acute phase of the inflammatory response and the
effect of WP were investigated at 6 and 24 h after
wounding. The increase in these inflammatory cyto-
kines as a result of neutrophil infiltration during the
early phase after wounding is particularly essential for
debridement and the clearing of infection by the ab-
sorption of wound exudates [6,48]. Neutrophils, which
are the first cells to arrive at the wound, eliminate mi-
croorganisms and then undergo apoptosis. Afterward,
neutrophils are rapidly and efficiently consumed by
macrophages in a process that does not lead to further
inflammation [36]. In the present study, we assessed
the effect of WP on these inflammatory cytokines as
well as on the anti-inflammatory cytokine IL-6, but dur-
ing later periods, at 2, 4 and 8 days after wounding in
normal and diabetic rats.
The serum TNF-α level was moderately increased in
non-diabetic rats as a result of wounding, but it was
strongly elevated in the wounded diabetic rats 4 days
after wounding. The serum concentration of IL-1β wassignificantly increased in wounded non-diabetic rats
on day 2 and 8 but was not significantly affected in
wounded diabetic rats compared with the correspond-
ing uninjured control. The serum IL-6 level was signifi-
cantly increased in wounded non-diabetic rats, but it
was not significantly affected in the wounded diabetic
group. However, levels of the anti-inflammatory cyto-
kine IL-10 in serum were significantly decreased in
wounded non-diabetic rats but were not significantly
affected in wounded diabetic rats. From these contrary
results, it can be concluded that the deterioration of
both inflammatory and anti-inflammatory cytokines in
diabetic rats may play a crucial role in the delay of
wound healing in diabetes mellitus.
WP treatment of wounded animals in this study did
not significantly affect serum TNF-α, IL-6 and IL-10
levels after 2 days. When the treatment period was
extended to 4 days, the levels of the inflammatory cyto-
kines TNF-α, IL-1β and IL-6 decreased. The decrease
in IL-1β and IL-6 levels continued as the treatment
progressed for 8 days in both wounded non-diabetic
and diabetic rats treated with WP, whereas the TNF-α
concentration was unaffected in treated wounded dia-
betic rats after 8 days. The concentration of the anti-
Figure 7 Effect of whey protein administration on serum IL-10 concentration in wounded normal and wounded diabetic rats. WP
induced an increase in serum IL-10 levels, especially on the 4th day after wounding and treatment. Non-wounded N; wounded normal: N; Whey
protein-treated wounded normal: WPN; Non-wounded diabetic: Non-wounded D; Wounded diabetic: D; Whey protein-treated wounded diabetic:
WPD. F. Prob.: p < 0.001; LSD at the 5% level: 20.37; LSD at the 1% level: 27.44. The means, which share the same superscript symbol(s) are
non-significantly different.
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http://www.biomedcentral.com/1471-2172/14/31inflammatory cytokine IL-10 in serum was signifi-
cantly increased after treatment with WP for 4 days,
but it was not significantly altered after 8 days of
treatment in both wounded non-diabetic and diabetic
rats. Thus, it can be suggested that WP initially and
acutely evokes the pro-inflammatory and inflamma-
tory response at 6 and 24 hours [16] and then hastens
the switch from inflammatory to anti-inflammatory
responses during the process of wound healing. These
findings agree with Peranteau et al. [49], who reported
that overexpression of IL-10, an anti-inflammatory
cytokine, decreases the inflammatory response to in-
jury and creates an environment conducive to re-
generative wound healing. Therefore, WP improved
wound healing in diabetic mice because it significantly
decreased the elevated pro-inflammatory cytokines
(IL-1β, IL-6 and TNF-α) and increased IL-10 in the
plasma and wound tissues. Based on these previously
described ideas, it can be concluded that WP limited
prolonged inflammation and modulated the immune
response during the progress of wound healing in both
normal and diabetic animals.An increase in free radicals and diminished antioxidant
activity may worsen the situation and account for the
delay in wound healing in diabetic patients. In the present
study, liver lipid peroxidation, which is an indicator of
oxidative stress, was markedly increased in wounded non-
diabetic and diabetic rats compared with the correspond-
ing uninjured animals. This result is in accordance with
Rosenbaum et al. [47], who suggested that oxidative stress,
regardless of its source, induces cellular dysfunction in
endothelial and smooth muscle cells and reduces angio-
genesis and the healing process.
In the present study, the treatment of wounded dia-
betic rats with WP profoundly decreased the elevated
lipid peroxidation and improved the antioxidant de-
fense system by increasing hepatic glutathione levels
and the activity of glutathione-S-transferase, glutathi-
one peroxidase and SOD. These results agree with
those of Ebaid et al. [17], who discovered an increase
in GSH level and a decrease in reactive oxygen species
(ROS) and hydroperoxide in the wounded tissue of dia-
betic rats after treatment with WP. This suggests that
WP may improve wound healing, at least in part, by
Figure 8 Effect of whey protein administration on liver oxidative stress status (A,B) and antioxidant defense system (C-J) of wounded
normal and wounded streptozotocin-induced diabetic rats. WP was found to stimulate the antioxidant defense system by increasing the
level of glutathione and the activity of glutathione-S-transferase, glutathione peroxidase and superoxide dismutase (SOD) in wounded non-
diabetic and diabetic rats. Non-wounded N; wounded normal: N; Whey protein-treated wounded normal: WPN; Non-wounded diabetic: Non-
wounded D; Wounded diabetic: D; Whey protein-treated wounded diabetic: WPD.
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http://www.biomedcentral.com/1471-2172/14/31the modulation of oxidative stress and the antioxidant
defense system.
In conclusion, WP hastens the wound healing process
in diabetic rats by limiting prolonged inflammation,improving hyperglycemic and hyperlipidemic states, in-
creasing insulin level, and amelioration of oxidative
stress and the antioxidant defense system. However, we
continue to perform further studies to assess the effect
Ebaid et al. BMC Immunology 2013, 14:31 Page 12 of 13
http://www.biomedcentral.com/1471-2172/14/31of WP on the phases of wound healing, including granu-
lation, collagenation, epithelialization and cicatrization
at the cellular and molecular levels.
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